TGM2 and posterior cortical atrophy: [149] demonstrated that silencing transglutaminase-2 (TG2) using CRISPR–Cas9 can affect the transcriptional regulation of MUC1 by inhibiting androgen receptor (AR) expression, leading to androgen insensitivity and malignancy in PCa cells.